These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14070392)

  • 21. Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine.
    JOHNSON IS; WRIGHT HF; SVOBODA GH; VLANTIS J
    Cancer Res; 1960 Aug; 20():1016-22. PubMed ID: 14407465
    [No Abstract]   [Full Text] [Related]  

  • 22. [VINCALEUKOBLASTINE, AN ALKALOID WITH ANTIBLASTIC ACTIVITY].
    MASCITELLI-CORIANDOLI E
    Boll Chim Farm; 1963 Nov; 102():745-50. PubMed ID: 14109586
    [No Abstract]   [Full Text] [Related]  

  • 23. Kinetics of micronucleated polychromatic erythrocyte (MN-PCE) induction in vivo by aneuploidogens.
    Morales-Ramírez P; Vallarino-Kelly T; Cruz-Vallejo V
    Mutat Res; 2004 Dec; 565(1):79-87. PubMed ID: 15576241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and SAR of vinca alkaloid analogues.
    Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STUDIES ON CATHARANTHUS LANCEUS (VINCA LANCEA). I. ISOLATION OF LEUROSINE, PERIVINE, AND YOHIMBINE.
    FARNSWORTH NR; LOUB WD; BLOMSTER RN
    J Pharm Sci; 1963 Nov; 52():1114. PubMed ID: 14079649
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical considerations on the use of Vinca alkaloids in an oncological radiotherapy department].
    Gualdi G; Anaveri G
    Cancro; 1968; 21():Suppl 6:155+. PubMed ID: 5740704
    [No Abstract]   [Full Text] [Related]  

  • 27. [VINCA ALKALOIDS IN ANTINEOPLASM CHEMOTHERAPY].
    MATHE G; AMIEL JL; SCHWARZENBERG L; SCHNEIDER M; CATTAN A; BREZIN C
    Concours Med; 1964 Nov; 86():6755-8. PubMed ID: 14236057
    [No Abstract]   [Full Text] [Related]  

  • 28. Total synthesis of indole and dihydroindole alkaloids. IX. Studies on the synthesis of bisindole alkaloids in the vinblastine-vincristine series. The biogenetic approach.
    Kutney JP; Hibino T; Jahngen E; Okutani T; Ratcliffe AH; Treasurywala AM; Wunderly S
    Helv Chim Acta; 1976 Dec; 59(8):2858-82. PubMed ID: 1017976
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of vincaleukoblastine on primary cultures of human neoplasms. A preliminary report.
    WALKER DG; WRIGHT JC
    Cancer Chemother Rep; 1961 Oct; 14():139-44. PubMed ID: 14004574
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical studies with the vinca alkaloids. I. Effect on nucleic acid formation by isolated cell suspensions.
    Richards JF; Jones RG; Beer CT
    Cancer Res; 1966 May; 26(5):876-81. PubMed ID: 5934799
    [No Abstract]   [Full Text] [Related]  

  • 31. Neurofibrillary degeneration induced by Vinca alkaloids: clinical and experimental.
    Shelanski ML; Wisniewski H
    Trans Am Neurol Assoc; 1968; 93():137-40. PubMed ID: 4304008
    [No Abstract]   [Full Text] [Related]  

  • 32. Acylation: a proposed mechanism of action for various oncolytic agents based on model chemical systems.
    Moncrief JW; Heller KS
    Cancer Res; 1967 Aug; 27(8):1500-2. PubMed ID: 6047880
    [No Abstract]   [Full Text] [Related]  

  • 33. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
    Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorimetric method for the determination of vinblastine, and alkaloid from Vinca rosea. I.
    JAKOVLJEVIC IM
    J Pharm Sci; 1962 Feb; 51():187-8. PubMed ID: 14036526
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioimmunoassays for the Vinca alkaloids, vinblastine and vincristine.
    Langone JJ; D'Onofrio MR; Van Vunakis H
    Anal Biochem; 1979 May; 95(1):214-21. PubMed ID: 495957
    [No Abstract]   [Full Text] [Related]  

  • 36. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP; Kavallaris M
    Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vinca alkaloids in the treatment of leukemia].
    Armstrong JG; Oclander G
    Prensa Med Argent; 1966 Jul; 53(28):1536-40. PubMed ID: 5989085
    [No Abstract]   [Full Text] [Related]  

  • 38. Vindoline and 16-demethoxyvindoline: two catharanthus-derived alkaloids.
    Ruszkowska J; Chrobak R; Maurin JK; Czarnocki Z
    Acta Crystallogr C; 2004 May; 60(Pt 5):o377-80. PubMed ID: 15131398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-(BETA-CHLOROETHYL)-3-CARBAMYLPYRIDINIUM CHLORIDE. PROTOTYPE OF A NEW CLASS OF LATENTLY CYTOTOXIC POTENTIAL ANTITUMOR AGENTS.
    FRIEDMAN OM; POLLAK K; KHEDOURI E
    J Med Chem; 1963 Jul; 6():462-3. PubMed ID: 14184911
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioanalysis and pharmacokinetics of (investigational) vinca alkaloids.
    van Tellingen O
    Pharm World Sci; 1994 Jun; 16(3):164-6. PubMed ID: 7920369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.